throbber
Quality heaith plans :5: benefits
`Heaithlerliving
`Financial well—being
`
`intelligent solutiorm
`

`
`2015 Aetna Pharmacy Plan Drug List
`
`Three Tier Open lndividual Plan
`
`www.aetna.com
`
`n=R2o15—o'1o99 '|R2D15-01097 |PR2015—01‘!00 |PR2O‘l5T-01105
`
`Lapin EX1078 Page
`
`f
`
`

`
`Do you have questions?
`Call the toll—free number on your member ID card. Or visit
`www.aetna.com/formulary for the most up—to—date information.
`
`Dear Member:
`
`To help you know how drug. are covered by your plan. we
`are pleased to provide you with a copyofour ANS Aetna
`Pharmacy Plan Drug l.|
`t.
`
`This guide provides helpful informaton about your pharmacy
`benefits p1an.You l'l1.:V want to take this guide w-thyou when
`you see your doctor to talk about what IS covered under your
`plan and what you can expect to pay ‘or your medione.
`
`Many commonly prescribed drugs are listed in th s ciuide Please
`remember this is not a complete l'st ofclrugs covered under your
`plan. Because thousands ofdrugs are l"ClU£l9d in your plurmacy
`benefits plan. we only list the most commonly prescribed ones.
`
`What pharmacy benefits plan do 3 have?
`
`You are enrolled in the Aetna Three Tier Open
`Individual plan.
`
`Here's what that means to you‘
`
`Think of tier as a level Three Tier means you could pay three
`different amounts. depending on the drug you take.
`
`A formulary l5 a list of generic and brand-name drugs that your
`health plan covers. An open formulary means your plan covers
`most prescri,-.it:on drugs. But it may not cover some others.
`
`What can I expect to pay?
`
`with this health benefits and health Insurance plan. the amount
`you pay depends on the drug your doctor prescribes. it's either
`a flat fee or a percent of the prescriptions price.
`
`What you pay Falls into one of these tiers or levels:
`
`Tier One: Generics—You pay the lowest cost for drugs in
`this level. Your plan may Include an additional benefit where
`some Tier 1 drugs would be provided at an even lower cost to
`you. These are considered Value Drugs/Tier la and include
`generics and some over-the— counter brand and generic
`products. These would be available at the lowest cost snare
`indicated in your plan materials.
`
`Tier Two: Preferred Brands — You pay a slightly higher cost
`For drugs in this level.
`
`Tier Three: Non-Preferred Brands — You pay the highest cost
`For drugs in this level.
`
`To find your exact costs
`
`Check your Plan Design and Benefits SUi"\".".‘Ial'y. Ti‘.lS should be
`in your enrollment kit.
`
`Your pharmacy benefits plan may include a program that
`encourages you to choose a generic drug over a brand-name
`drug, in order to help reduce wwat you pay. T' is means that
`ifyou fill a urand-name drug when a generic lS available, that
`in addition to your standard copay or coirwurancn you m..=t
`also pay the u‘-tference in cost between the br..-- .d~name and
`general. drug.
`
`For a summary ofyour pharmacy benefits plar~_ lncludi-g
`our-of-pocket costs. v sit www_ae tna.com and .- =9 in to Aetna
`Nay gator. Or call the toll-free number on your member ID card.
`
`www.aetna.com!FormuIary
`
`Page 2
`
`

`
`Where can I find more Formulary information?
`
`Why is the formulary subject to change?
`
`You and yo .r doctor can rearc“ For a drug, ‘ind out i‘ it's covered
`and s- -3 what tier i. ia!'s ur-rler Vriu can also see if there are
`alternatives that cost less. Make sure your doctor knows that
`you pay more For two and three tier drugs. He or she can
`consider this beFore writ ng a prescri‘ iion.
`
`Take these steps:
`
`1. Visit w_ww.aetna.comlformulary. ‘rou arrive at a page trial
`says "Medication hearch."
`
`2. This is where you can learn more about the types of
`drug coverage reviews yOUF drug requires: ll» rigs | -:e
`prei.ertif.r.atlon, sten therapy or cuarrtity limits. You will
`arr re at a menu page wh eieyou can .i
`- w various driiq lists,
`including your Aetna Pharmacy 'r..;n Drug i_...t and more.
`
`How is the formuiary developed?
`
`Aetna's Pharmacy and Therapeutics lP&T) Committee meets
`regularly to review new drugs and new information about
`drugs that are already on the rnarli-at
`t reviews available
`information concerning s.iFety. ef'Fec. rennss and current use
`in the racy The P&T Corn.-~ iiee reviews scii.-ntiric evidence.
`including relevant findings oF Federal governrnerit agencies,
`pharri aceutica, mu nufacturers, medical prnfessio rial
`associatons, nat.onal commissions and peer-reviewecljournals.
`
`0 ur P "rT Committee includes licensed pharmacists and d octors,
`including those who are currentiy in practice and others who are
`Aetna employees. Al' committee meriribers must tell Us if they
`are in a situation that can create a conflict oF'.ntorest or ifthey
`have a Financial stake that l"'l!__}.".[ af.‘i_-.;t their decisions.
`
`Once the l‘SiT Committee completes its c.in.cal review, we
`also corisider overall value (incl-iding cost and rrianufacturer
`rebate arrangements) and other Factors beForr- ad: l’rig or
`removiriq a drug from :l'ie Forrnulary. Aetna Pharmacy Plan
`Drug List shows you recent changes to the guide. For example,
`it could shuwwizat drugs started renu ring coverage reviews .il<e
`precertification, step t-‘iercipy or quantity |
`i-- is Or which drugs
`no longer do. The Pi5rT Corn mi.tee can rriake recommendations
`to change the tier level oFa drug or to place :on our Forniulary
`Fiiclusions List, designating it as a drtg that is no longer covered.
`
`Vie ma . Add or remove drugs for certain reasons. We " grit
`also move a drug From one coverage [Ir
`‘
`~ another.
`
`Here are some reasons w"‘y.
`
`- As branc’ name drugs lose their riatents and generic versions
`become available, the brand-name may be covered at a h gher
`out-oF- pocket cost whle th e generic ma‘, be covered at a lower
`out-oF— pocket cost.
`
`- The Food and Dr..g Administration (FDA) approves many
`new drugs throughout the year.
`- Drugs can be withdrawn from the market or may become
`available without a prescription.
`
`Our website, www.aetna.con1/formulary, reFlects the most
`up-to-date Forrnuiary information - so please visit it ..Ften.
`
`Why do some drugs require prior authorization
`or precertification?
`
`This drug coverage review encourages appropriate and cost-
`ef‘ec;..ie use o.‘ prescription drugs by al'owing Coverage only
`w'ien certain conditions are met.
`
`Reasons For precertification include:
`
`' Compliance with closing guidelines
`- Avoiding duplicate therapies
`
`- Helping health care providers check that a drug is being
`used based on generally accepted medical criteria
`
`The nrecertification program ‘.5 based upon current medical
`I .ndings, FDA-approved manufacturer labeling information,
`and cost and manufacturer rebate arrangements.
`
`lfyour plan requires precertification. you vii” find a list ofdrugs
`that are subject to precertification vi .th this guide. Please keep
`the following in mind:
`
`- Your doctor must contact Aetna to request approval of
`coverage for these drugs,
`' lFwe approve the request, we will '1oHFy your doctor. The
`drug will Llien be covered at the arinilcable out~oF—pocket
`cost under your plan. You w'i.i also be notilied ofappro wls
`where the state requires notification to "iel'l'llJEl'S.
`
`|Fthe request is denied,you and y :u' doctor will be notified.
`You can stiil purchase the drug, -‘-i it ft,
`the Fi_.ll price.
`
`www,aetna.r:omJ'formuIary
`
`Page 3
`
`

`
`Why do some drugs have quantity limits?
`
`Saving on prescriptions
`
`This drug coverage review limits coverage o'.1uantities for
`certain dr. .95. These I mits heiri your coctor and Phal'iT|aC|a[
`check that your prescribed drug 5 used correctly and sui ciy.
`
`We use medical gu delines and FDA-approved recommendations
`rrom drug makers to set these coverage iirnits. The quantity Iirnit
`program includes:
`
`- Dose Efficiency Edits — Limit coverage of prescriptions to one
`dose per day for drugs that are approved For once— daily dosing.
`- Maximum Daily Dose - A message is sent to he pharmacy
`ifa prescription is less than the minimum or higher than the
`maximum allowed dose.
`
`- Quantity Limits Over Time — L mit coverage of prescriptions
`to a specific number ofunits in a defined amount oftime.
`
`What is step therapy?
`
`This drug coverage review promotes the appropriate use
`CF equally effective but lower-cost drugs first Prerequisite
`drugs are FDA-approved and treat the same condition as
`the corresponding step therapy drugs.
`
`What is therapeutic duplication?
`
`Therapeutr: duplication means that two or more drugs of
`the same type are prescribed at the same time. This can occur
`when two doctors prescribe similar drugs or when your doctor
`switches from one drug to another drug in the same class
`without cancelling the first prescription.
`
`it is rare that you should ever need two drugs From the same
`class to treat a medical condition. Since serious side effects
`
`may occur, we help bring such ClUpllLiJi.iDl'lS to your pharmacists
`and doctors attention.
`
`Learn more about drug coverage reviews
`
`lfyou have a medical need For a drug that requires prccertifcatiori,
`quantity limits or step therapy. your doctor can ask for a medical
`exception. The list ofdrugs requiring preceriificat on, quantity
`limits or step therapy is subject to change Find the most
`up- :o—o..ite information at www.aetna.comIformula ry.
`
`You may be able to save with generic drugs
`
`Generic drugs are approved by the U.S. Food and Dr..g
`Administ:-iiion lFDAJ and proven ;o be,ust as sa re and effective
`5." brand—name drugs. T ney contain the same active ingredients
`ir the same amounts as the brand name products. The
`
`difference .. that generics may be a different color, shape or size.
`
`Whe appropriate your doctor may decide to prescribe. or allow
`sut-r‘ r.u'
`» ii with, a generic drug. Please talk to your doctor to
`find out I‘ a generic is right foryou.
`
`Here are some other tips to pay less out ofpocket ‘oryour
`prescription drugs:
`
`' Ask yourdoctor ‘ 3 consider prescri'r- ng generic drugs
`ins ‘cad rifln'ano- name drugs.
`
`- Ask youi doctor to consider prescrib ng drugs that are
`on the Aetna Pharmacy Plan Drug List.
`
`' Check to see ifyour plan .nciude5 our mail-order pharmacy
`service Depending upor your plan. mail order may save you
`money. bee Aetna Kit Home Deiivciy‘ .n ll .35 guide ‘or details.
`- Remind your doctor to check your plan to make sure you
`get maximum coverage.
`
`What is Aetna Rx Home Delivery?
`
`Ch eck your riian documents to see ‘if your plan includes
`our Aetna Rx Home Delivery moi!-order pharmacy ‘is Fills
`presc: ip;ions for maintenance medic iie. This type of medicine
`is used regularly, to treat conditions .i~-2 al'lhf|'ti5, asthma,
`diabetes or high c‘ i"-lesterol. lfyou need th is type ofdrug, you
`can get up to a 90-day supp -2, or the max.-num supoly allowed
`by yui..r p..,=n, and free delivery 'ig"Il2 to yocr ma..‘l.iox.
`
`You also get:
`° Qu-ck, confidential service
`
`- Free standard shipping
`- Pharrnac ' ts who c"~eck all prescriptions For accuracy
`and can answer questions any time
`
`It's easy and fast to order- choose one of these ways:
`
`1. Mail — Get a new prescription fror your doctor, Mail
`your new prescription to Aetna Rx Home Del'.very w .th
`a completed orrler forrri. You can access the form online.
`Visit ww\iv.aetna.corn and 3'19 in to Aetna Nuiiiqator,
`your secure member website Orynu can go right to
`www.aetnanavigator.corn. Once ogged in. riick the
`link to ‘Aetna Pharmacy".
`
`2. Fax — Give your rioctor the Aetna Rx Home Delivery fax
`number: 1- SH 2 10-3317. Your doctor can fax in the
`
`prerrr.p..0n. Make sure your doctor includes your member
`‘D number. yo.. r date ofuirth and your ma. ng address on
`‘.:ie fax cover sheet. Only a doctor may fax a prescription.
`
`3. Phone — To help make tr-asy to get started. you can also
`choose to use our Act." iRx Courtesy Start“ program. Call
`the toll-free number all your member ID card Ask u< to rnac '1
`out to your doctor. We can l""‘.lJ'eSlL a new 9u i:.:. prescription
`ony-~ii
`)L‘l"
`if ‘I ur ioctor rt‘ ll l'l""dy1Ui’1<Cl'l€~.iult. a vi;i.t
`before he or -he i.
`I ivrize you 3 nr_ii. p|‘€"CI'|pl.lO|'1. After we
`reach out to your doctor. ninase ailow time _u;, to 7 day’-i ror
`i.s to re-'.-we a reply fo he p this process rruve quickly, please
`alert your doctor to expect our call.
`
`I’ your pres-rr? 7-tinn is for a contro rid mec'.ic.ne_ a written
`prescrip; on from your doctor may be needed.
`
`Gene - Iy. ‘fyour order is compiete-,y uui. ' receive your
`Fl'IP(" N-rt vi thin I i-‘4day5 from wh-' " Aeir i Rx Home De’ .ery
`rec.
`/E -yui. r order
`rou can requestexpeditr-d delivery for or
`.id:.‘..;.onal charge.
`
`www.aetna.com/formulary
`
`Page 4
`
`

`
`What is Aetna Specialty Pharmacy?
`
`Aetna SDt:‘CITill.)’ Pharmacy is Ar.-tna's in—huuse specialty
`p‘1'=.rmaCy. It cm ffi your nrescnptien specialty medit ne.
`These types of drugs may be injected. infused er taken by
`mouth. Specialty medicine oFL.=rv needs specia;
`; sruqe and
`har*r‘l'ng. It must be deliver-;-.1 qu.cl-'.ly. And a nurse or pharmacist
`should monitor you Gui mg your treatrnr.-. -t. Use Aetna Specia.ty
`Pharmacy to get this medicine sent right tr: your maflhnxl
`You atS-J get;
`
`- Free delivery that is reliable, secure and sent anywhere
`you choose
`
`* Extra help when you need it— like uuection training and
`side effect monitoring
`- Proactive outreach to Confirm your refills
`- Free Standard sunplies
`
`- Nurses and pharmacists who can help you 24 "Iours a day,
`every my
`
`It's easy and fast to order - choose one of these ways:
`- Fax —Ynur doctor may ‘ax your prescripL.un to
`1-866-FAX-ASRX (1-866-329-2779).
`
`° Mail -- You or your doctor may mail yaur pmscrmtinn order to;
`Aetna Specialty Pharmacy. 503 bunport Lane. Orlando. F L 32809.
`Ifynu ma I in your own prescription, please send it along 9. ith
`a completed Patient Prnfii-2 Form. To access this ‘arm, visit
`ww-w.AetnaSpecialI:yRx.corn and click “Specialty pharmacy"
`How to enroll.”
`
`- Phone — Your doctor may also call and speak to one
`of ou r reg: stered pharmacists at 1 4366-182-ASRX
`(1 -866-732-2779} during normal business hours of
`8 am. until 7 p.m. ET.
`
`To transfer an existing prescription order to be filled by
`Aetna Specualty Pharmacy, cull toll -Free at 1-866-353-1892.
`
`www.aetna.comlFormu|ary
`
`Page 5
`
`

`
`Need more information?
`
`Visit www.aetna.com/Formulary or call the
`appropriate toIl—Free number on your member ID card.
`
`rerai_,e. Plan Features
`
`Please note thai if» ur i:- ‘I’! ption drug benefits plan char ;es, the nformation herein may no longer apply,
`A copay: - Ient is a I" :’ Fee. Coinsurance is a percentage it ‘l erate ihfil Aetna negotiates with the plan snonsor for rovered prescriptions exi V .r as required bylaw
`to be otherwise 7
`2 drugs on the Preferred Drug List are so 1ier;; in manufacturer rebates. Coins .-rani.e is calculates before any :eI:ia'es are subtracted. That
`means It may be possible "W yuuri nst nfa preferred r:iri.3 to be higher than your cost ofa non-preferred drug.
`Heal’ n benefits anu health insurance ,.-‘ans are offer-rl. administered aiidlr-r underwritten by Aetna Heaitii ‘nt Ar.-Ina Heallh insurance Company ofNew Yr rli,
`Ae'na Health "1‘l'l'-'InCE Company aiidiiv Aerna Life Insurance Company liletna). In F.:~ri:Ia. by Aetna Heaith In
`an it.
`- Aetna Life Insurance Company
`i
`Marylin. 1, by Ae;na HP?" 1 lnc.. 151 Farnii: 5'
`1 Avenii-, Hortio cl, CT “5156 Each insurer h is sole tlnznt at '5 '.pons'ibili'_y for its
`"\'n products. Aetna Pharmacy
`Mariagerr~enI:re'—rstnanInteinaIbi.i_- mes: uiiitofAetiiaHenlrhivianrigement,LLC.Aetna5per'Ia|:yPharmnryrefer5toAetnaSpeciaityP'1ari'- iry,, I,f__asubsldIary
`ofAetna Inc
`.-. r- :h is a
`Pl. Ii rt nharrnacy that operates '-'iri.-u.,h specialty pnarmacy prescription fuifiliiiii rt
`Not ail ' Ml" ‘i serviri . are covered. See plan documents for a l nmpictu description ofbenelits, ext
`1'‘
`~ is. limitations and conditions of
`and avaiiabnizy
`.iy iai y by In
`itlrin and are subject to chani_.e
`SP~ Drugs listed die ni-I
`< :--d by our Aetna's Specialty Health Lare Mananement“ nurse E--Irn. Mer-hers ri-re . i-. he support of this team thruugl-ii .iit ‘ he ei~'2-i-
`course of therapy ' us in ' ii er'1pi... I A 'sp|"-' I’ Caper‘
`I-3 provision this means in»: half ciFa one month s ruppiy r‘ medicine . .i
`‘Mi at a timr
`'.; Iii fill
`r‘
`r
`- 1sii-igallows the nurse :ear to 4|!!!’ more support, incl-Ii" ng more I'i,‘l
`.v up tr monitor response ti: tfealme uaiij I
`-tar‘
`il ri.-acti.
`or
`"E-er-feC[5.T‘!i5
`help - pieiier twasterl merli
`vie and saves members rn i-I--v ii :hi.-ir medicine i
`r dose changes between l'i'is This I‘ t is r ,' 2.‘ -ini
`rive and 5 subject to change.
`Aetna IELEIVUS reuiites ‘. r
`-1 dlug man-ilai:ti_---rs that n ay be taker
`win account n deterrrmii .9 Aetr-1'; Preferred Drug Llst Rebates do N. t iedi e the amount a
`member pays the pharma vfoi L’
`rered .1rescriptiuns.lnforrr 3' n is su:
`i-
`ti..i change. For more infurrnatiuii about Aetna plans, refer to wiii-w,aetr I i.i.iiii.
`The drirns El‘ "re Preferred l
`g L
`r,F rrr ;l -iry Exclusions -‘recei: " ration Quantity L:'r: t and Step Therapy Listsare sumac: to change The quantity Iim Is and
`step therapy dn 3 coverage review pi
`,-rams arr rint available n ail service areas. For example step therapy ;.:
`:rams "in nor appiy tc Fi.
`';,i-iiisiired merr. --rs in
`I
`. Iiaria. ‘ - ep ;herapy doesr-r . apply to ‘HI y- nsured members in Newlersey However. these programs are available to sr-I’ funced plans
`;
`lnacrnrrfrncewith ‘atela i.
`mrriefcialilu .
`‘
`i'e.*lrriembersin Liiur
`I
`is. ant: TexasIexceptFederalE"'Iplnvr-e-i
`i"hHr=ns-ii Planrr-err‘: zrslwhoarere eiu
`I
`c
`-eiage tor medications [h.‘LaII,‘ uddtd iir removed fr’ m the ='reF-erred Drug List I-‘recertirication, Oiiantit-, ._In- Its .
`r 'iieIi~ihera y Li
`5 dl" " ; tne panyeai ii.
`C..inl[II‘|UE‘ -have
`I
`’-
`‘ca’
`-a co-«ered at xmsar -A hene'it level uni.‘ their piiin s renewal dare In Texas, |3reCE"l|5iCa[
`‘ippi. iii
`-.Iri-inwn as “pre-service
`iiti'izati:.iii review
`is 1 3 ‘verification’ as defined 7yTexaslaw
`' who are 'ern.iiinq
`‘tyee Heaflh Benefit than mvnt
`In at
`i
`i
`e with *
`aw ‘-il|y- '" "ed Coniineri
`l.aIIForr‘1 HMO members lexcept Federal Em:
`coverage foi rr ea .
`ti:
`that are added to the Precertiiicaliuii i-r‘ "rep -theraiiy Listsw-II cor‘ - ue to have [hr 43 medications covereu, for as lciiiii as the treatinr
`I: iysu. in CD|'|’
`-ipfescr .
`I Hi
`'
`in I
`in I the the drug iappi Jpllu ‘ely prescrlhr land is considered safe aii ‘
`> "-
`.-o 'nr treat
`;: eer"
`g--
`:I'|- ‘
`~
`I
`'1"
`i In arrr rmce i.
`'hstateliiii.
`ii.
`.-Ifl‘-IlI'P¢"l ('nrr1"11P|'
`iconrii zt \,U[l‘F0fTlFl'|'|hEFS‘QXC|'-‘F =ei:Ier._- 5--ploy.-eH~.
`'2 -liarw-fir. I-‘ in "'l9|""b9'
`I-
`.
`ire
`:
`'fi.=ir
`ieranelerrner‘ cii; us thatare ado.
`‘
`ithn“rPrP"
`_..ilI
`rSti.-p-therapyt sts will ‘or
`i etc h
`,-'-th"semi.-Jli.i'
`.r ed "‘ ar
`3 -sthe
`..eatin .,.‘ ,‘>-\
`ii p|'E:"|'Ih"S{h( n. piOV|u'uJ the drug is nr.-i.’
`e winincesr i-yand more medicallybenefi althan othercr iered i;i.i_,;. r~..,.ii .i,
`'ii5 qr
`wt ‘\-‘ill
`~
`plerl-H the.
`‘
`ipi
`‘er In In hresrril‘i' _
`-i... We! drug c .-rered by We plan that is merically app .,-riate for the i;-nrollee, nor shaii tJIIJ
`iiiii-,
`this
`i
`s.
`i1 he ‘nn<?'-..t.' Jpii
`tgerieri
`I,~snh<r‘ii
`,r
`This "'4 -I 11
`Ft" inforrmlii
`‘I iIlv I‘ ‘flniain-3 n-
`uuiur
`-ntsf
`.c
`lete cle.
`»I.iDr‘I ul bflne’ ‘‘ err
`Sub ecttar
`re -’rmi ‘l"Is..e depend:
`\.
`care or 5i.i.iia- eea
`es'
`ih-aim service: Inforrrs
`
`-n
`I
`*
`'10:". hr‘? crmstitute a contra-' '
`'lT'I5 ar ‘l
`-n ofrlin benefits or pru._.
`.I-iartiai 1( “Hal (‘es-‘ i:
`and are
`ns -“crwn-r=rJr= Pan Featuresa '|dhullat|Ii '
`I maywry ,. scat.
`I
`"‘ itiiii.
`J) iiiiu L.
`rarer‘ Lagents ciFAetIia P-
`.
`ierp Ii‘i-
`....i.
`‘int’ 1 chan_
`rut
`--
`-1 Pie‘
`i'inP5 rirz. ,,.. de
`,.
`'[( change_For more iliiriiatir-i ah
`til\¢.na p.aris_reri>r _.)www .iei
`i.
`-r.
`
`-
`‘
`,il!|§ ..
`
`3’!-I
`:
`1.395 ..t
`
`‘
`
`' 3115)
`
`Page 6
`
`

`
`2015 Aetna Pharmacy Plan Drug List ~ Three Tier Open Individual Plan
`
`Table of Contents
`
`.
`
`M.
`
`.
`..
`MM
`
`.
`
`MM
`
`......
`.
`
`.
`
`.......
`
`..
`
`.
`
`...
`..
`_
`..
`
`M
`
`.
`
`..
`
`.......
`
`MM
`
`.
`
`MM
`
`M
`
`M
`
`.......
`
`TTTTMM
`
`M
`
`..
`
`,
`
`..
`
`.
`
`.
`
`..
`
`..
`
`MM
`
`..
`
`M.
`
`.
`H
`.
`
`.
`
`..
`
`.
`
`.
`
`‘I
`
`MM
`..
`
`M
`
`.
`
`_
`
`..
`,,,,,,MM
`
`M
`
`M
`
`..
`MM
`
`.
`
`,,,,M,
`..._
`
`___.___H.__'?=3Ln-hi‘-‘-wL»Jwr~.)\DuoO\a«_O\L.4
`
`.
`
`..
`
`..._
`..........
`
`..
`
`_
`
`_
`
`_
`
`MM
`
`.
`
`MM
`
`......
`
`MM .. ..
`
`.
`
`*ADHD/ANTI-NARCOI .EIPSYIAN'1 I-OBESITY/ANOREXIANTS‘
`*AMEBICIDBS*
`..
`*AMINOGLYCOSIDES"
`*ANALGESICS — ANTI-lN}~'LAMMATORY"'
`*ANALGESlCS-NONNARCOTIC*M.MM,
`*ANALCiESICS - OPIOID*
`.
`*ANDROG[-‘NS-ANABOLIC*__.M......MMM.M..., MM
`*ANORECTAL AGENTS"‘MM,,,
`..
`_
`..
`..
`*ANTHELMINT]CS*
`"‘ANiT|ANGINAL AGENTS*
`"ANTlANXIE’I'Y
`..
`..
`M
`*ANTlARR_HYTHMICS* ,
`..
`*ANTlASTHMATIC AND BRONCI-IODILATOR AGENl'S‘.....
`*AN'I‘l('0AGL,'LANTS"
`.M MM
`MM
`MM
`,
`,
`.. .. ,
`*ANTlCONVLI.SANTS"‘
`.
`
`..
`
`..
`
`.
`
`*ANTIDIABLTlCS"
`
`M
`
`M
`
`,
`
`M
`
`
`
`MM
`
`.
`
`MM
`
`.
`,
`
`MM
`
`.
`
`MM
`
`. ..
`.
`M ...........................
`_
`
`..
`
`MM
`
`MM
`
`MM
`
`,
`
`_
`
`.
`
`M
`
`_
`
`_
`
`.
`
`.
`,
`......
`
`MM
`
`MM
`
`"
`
`.
`
`..
`..
`
`MM
`.
`
`MM 17
`. I8
`
`_
`
`MM
`
`...24
`
`.
`
`,
`
`.
`
`_
`
`M
`
`_
`
`.
`
`.
`
`.
`
`"
`
`.
`
`.
`
`_
`
`_
`
`_
`
`M
`
`..
`
`..
`
`_
`
`M.
`
`_
`
`..
`
`..
`
`MM
`
`.
`
`*ANTIHISTAMlIN ES‘
`*ANTIHYPERLIPlDEMICS*...
`,
`*ANl'lHYPERT}.;NbIVES*M
`*ANTl-INFECTIVE AGENTS — MISC.*
`M
`__
`*ANTIMALARIALS*
`,,,,,,
`MM
`.
`_
`*ANTIMYASTHENIC/CHOLRNERGIC AGENTS*......
`MM
`*ANT]MYCOBACTER]AL AGLNTS*
`_.
`*ANTlN‘EOPLASTlCS AND ADJUNCTIVL THERAPIES"‘
`*ANTiPARKlNSON AGENTS*
`..._
`.
`..
`..
`M
`*ANTlPSYCH(Jl ICSIANTIMANIC AGENTS*
`*ANTl\/IRALS‘
`IV
`MM
`_
`_
`
`.
`
`.
`
`MM
`
`MM
`
`MMMM
`
`M
`
`M
`
`M
`
`M
`.
`
`__
`
`.
`
`MM
`
`.
`
`..
`
`M
`
`MM
`
`MM
`..
`
`.
`
`..
`
`,
`
`.
`
`.
`
`..
`.
`
`.
`
`..
`
`MM
`
`.M
`
`M
`
`.
`
`MM
`
`..
`
`..
`
`,
`
`_
`
`.
`
`.
`
`.
`
`.,
`
`M
`
`M
`
`MM
`
`..
`
`M
`
`.
`
`..
`
`M
`..
`
`..
`,
`
`,
`
`M
`
`MM
`
`30
`,,,,M. 32
`34
`M 38
`_ 39
`39
`40
`_ 40
`44
`45
`48
`
`..
`
`M
`
`,
`
`MM
`
`_
`
`..
`MM
`
`MM
`
`,
`
`_
`
`M
`
`M
`
`MM
`
`..,..
`
`*ASSORTED CLASSES*....
`..
`"‘BbIA BLOCKI:.RS* _
`*C/\LClUM (‘HANK LL BLOCI(ERS*
`*CARDIOTONICS"'
`*CARDIOVASCULAR AGENTS - M]SC.*M M
`*CEI‘HA LOSPORINFH‘
`*CHI:LMIC‘\LS*
`*CONTRA( LPTIV l‘H*
`.
`*CORTlCOSTERO]DS*
`*Cf)lJGHlL‘0LDfALLERGY*
`*DERMATO|.0(3lCALS*
`*DlAG\IOS'I'lC PRODUCTS*
`*DIETARY PRODUCTS/DIETARY MANAGI MENT PRODUCTS‘
`*D]GE:iI NF. AIDS‘
`..
`M
`M
`*DlURETlCS*
`‘ENDOCRINE AND METABOLIC AGEIN 1'5 - MISC.‘
`*ESTRU(:l-.NS*
`..
`*FLUOROQLlNOL0\l 8*
`
`,
`_
`
`M
`
`_
`
`_
`MM
`
`_
`
`MM
`
`MM
`
`..
`
`M
`
`..
`.
`
`_
`
`_
`
`_
`
`..
`
`_
`
`.
`
`M
`
`_
`
`M
`
`_
`
`M
`
`..
`
`..
`
`_
`
`..
`
`,
`
`MM
`
`MM
`
`M
`
`51
`53
`54
`S5
`56
`57
`53
`58
`63
`64
`65
`75
`75
`77
`77
`78
`82
`33
`
`_
`
`..
`
`M
`
`M
`
`_
`
`..
`
`M
`
`_
`
`_
`
`..
`
`MM
`
`.
`
`_
`
`M
`
`MM
`
`Page 7
`
`..
`M
`
`_
`
`MM
`
`M
`
`..
`
`..
`
`.
`
`M
`
`,
`
`_
`
`M
`
`._
`
`..
`
`MM
`
`MM
`
`MM
`
`_
`
`M
`
`

`
`I
`
`M
`
`M
`
`M
`
`M.
`
`M.
`
`MM
`
`M
`
`MM
`
`M
`
`MM
`
`MM
`
`MM
`
`M
`
`M
`
`M
`
`M
`
`MM
`
`I
`
`II
`
`M
`
`M
`
`M
`
`M
`
`M
`
`M
`
`M
`
`MM
`
`M
`
`M.
`
`M.
`
`M
`
`M
`
`V
`
`V
`
`M
`
`M.
`
`M
`M. M.
`M
`M. M. M MM M
`MM
`
`M
`
`M
`
`M
`
`MMMMMMMM
`
`M.
`
`MM
`
`M.
`
`M
`
`MM
`
`M
`
`MM
`
`MM
`
`M
`
`M
`MMMMMMM M
`I‘
`M.
`M
`MMMMMMMMMMMMMMMMMM
`M
`
`M
`
`M
`
`M
`
`MM
`
`MM
`
`M
`
`MM
`
`M
`
`M
`
`M
`MMMM
`
`V
`
`M
`
`M
`
`‘
`
`M
`
`V
`
`M
`
`M
`
`M.
`
`M.
`
`M
`
`M
`
`M
`
`MM
`
`MM
`
`M
`
`M
`
`M
`
`M
`
`M
`
`M.
`
`M
`MM
`M
`M MMMMV
`M
`
`M
`M
`MMMMMMMMMMMMM
`MMMMMMMMMMMMMMMMMM
`
`__
`
`M
`
`M
`
`MM
`
`M
`
`MM
`
`M 34
`86
`87
`87
`M83
`90
`90
`91
`92
`M
`M MMM.92
`95
`M 96
`97
`97
`M99
`M 100
`100
`101
`
`M
`
`M
`
`M
`
`M
`
`M
`
`M
`
`*GASTROINTE-LS FINAL AGENTS - MISC.*
`*GEN]TOURlNARY AGENTS - MlSCELLANEOUS*
`*GOLT AGENTS*
`M.
`M.
`M
`"‘I-IEMATOLOGICAL AGENTS - MISC.‘
`*1-IEMATOPOIFTIC AGENTS*
`*1-IEMOSTATICS*
`*HYPNOTICS/SEDATIVES/Sl.I' [LP DISORDER AGENTS* M
`*LAXATlVI:;S* M
`M
`M
`*MACROLIDES"'
`‘MEDICAL DEVICF.S*
`*MlGRAINI_i PRODUCTS*
`*1\/IINBRALS & ELI:CTROLYTES*
`*M0UT}-LFTPIROATIDENIAL AGENTS*
`*MULTIV]TAMINS* M
`*MUSCULOSKELETAI.. THERAPY AGENTS‘
`*NASAL AGENTS - SYSTEMIC AND TOPICAL‘
`*NEUR0MIISCl4I..ARAGENTS*
`M
`M
`*OPHTI-IALMIC AGENTS* MM
`MM
`
`M
`
`M.
`
`M
`
`A
`
`M
`
`M
`
`M
`
`M
`
`M
`
`MMMMMMMMMMMMMM
`M V‘ M
`
`*OXYTOCICS*
`"'PASSIVE IMMUNIZING AGl_;NTS*
`"PLNICILLlNS"‘
`I
`*PI-IARMACEUTICAL ADJUVANTS*
`M
`M
`MM
`*PROGESTINS*
`M.
`M
`'PSYCI-IOTHERAPEUTIC AND NEUROLOGICAL AGEN FS - MISC.‘ MM
`‘RESPIRATORY AGENTS - MISC .*
`M
`M
`MM
`MM
`M
`*SULF0NAMlDBS*M MM
`MM
`M.
`*TETRACYCLINES*
`*TI-IYROID AGENTS* M
`M
`"ULCER DRUGS‘
`‘URINARY ANTI-lNFE.CTlVES*
`‘URINARY ANTISPASMODlCS*MM
`
`MM
`
`MM
`
`M
`
`M
`
`MM
`
`M
`
`MMMMMMMMMMMMMMMMMMMII
`
`MM
`
`M
`
`MM
`
`MM
`MMMMMMMMMMMMMMMM.
`
`M
`
`MM
`
`M
`
`M
`
`M
`
`
`
`MM MM
`M
`
`M
`
`M
`
`M
`
`MM
`
`M...
`VI
`
`MM
`
`M
`
`M
`
`AI
`
`MM
`
`M.
`
`M
`
`MM
`
`M
`
`IV
`
`1
`MM
`MMMMMMMMMMMMMMMMM
`MM
`M
`
`MMMMM..
`M
`M
`
`M
`
`MM
`
`M
`
`MM
`
`M
`
`M
`
`MM
`
`M
`MMMMMMMMM
`M
`
`M
`
`M
`
`MM
`
`MM
`
`M
`
`MM
`
`MM
`
`V
`
`M.
`
`M
`
`M
`
`MM
`
`M
`
`M
`
`M
`MM
`MMMMMMMMMMMMMMMMMMMMMMMMMM
`MMMMMMMMMMMMMMMMMMMMMMMM
`MMMMMMMMMMMMMMMMMMMMMMM
`
`M
`
`MM
`
`MM
`
`M
`
`*VAGINAL PRODUCTS*
`*VASOPRESSORS*M
`*VITAMINS*MMMM
`M
`
`MM
`
`MMMMMM
`
`MM
`
`M
`
`M
`
`MM
`
`M
`
`M
`
`MM
`
`MM
`
`MM
`
`MM
`
`M
`
`MM
`
`M
`
`M
`
`M
`MMMMMMMMMMMMMMMMMMMM
`MM
`
`MM
`
`M
`
`M
`
`I05
`I06
`M 106
`106
`107
`MM M 107
`110
`110
`MM 111
`112
`112
`115
`M 115
`
`I16
`117
`118
`
`Page 8
`
`

`
`2015 Aetna Pharmacy Plan Drug List - Three Tier Open Individual Plan
`
`Drug Status
`
`Drug Details
`=
`# =—' Brand-name drug expected to
`CE = Available to some
`become available generically in the
`members at no cost with a
`near future
`prescription from your
`provider when obtained at AL = Age Limit
`an in-network phammey.
`(‘opay Note '~ 3 Copzlys Required
`Certain limitations may
`DS = Not available :15 90 day supply
`apply.
`N1 = Step Therapy Not Applicable in
`LA = Limited Access -
`NJ
`Covered in Listed States
`N2 —Covered in NJ. IN
`NC *~ Not Covered Unless N3 = Covered in listed st:nc.s
`Noted Otherwise
`N4 —-: Covered at noted tier in DE
`
`Tier I == Preferred Generic PA = Prior Authorization Applies
`Tier 2 =4 Preferred Brand
`QL * Quantity Limit Applies
`Tier 3 : Non Preferred
`SF ——* Split Fill Applies
`Drugs
`ST = Step Therapy Applies
`
`lowercase italics = Generic drugs
`UPPERCASE " Brand name drugs
`
`t D-7usiS7=-tus
`
`
`*r\DH D/ANTI-NARCOLEl’SY/ANTI-OBESITYI'
`
`Ar\'ORE.\'lANTS*
`
`Drug Details
`
`*AMPHETAMlNES* *-*AMPHETAMINF
`
`
`‘MIXTI_JRES***
`
`DESOXYN
`D
`
`; _
`
`-_
`
`A rdexrroamphetumrne sulfate er
`
`.
`
`J
`CAPSUII
`
`'.
`
`.
`I X ll NIDED
`
`DS; QL
`
`PA; ST; D3; NI; QL
`DS; QL
`
`dextroamphetamme smljute oral solution
`
`Tier I
`
`QL
`
`20|5 Aetna Pharmaey Plan Drug list - Three Tier Open Individual Plan
`(Updated 08/01/20l5)
`
`Lp.l
`
`Page 9
`
`
`
`I
`
`’l‘ier 3
`
`QL
`
`Fier 3
`
`ST; E; QL; AL
`PA, QL
`
`
`
`
`ADDERALL XR
`amphetamine -trcxrroamph er er
`
`ampheramz'n..- —Jexrm; xmpherum ine om! tablet 1'!) mg,
`12.5 mg, 15 nr‘-5-, 20 mg. 30 rug, 5 mg, 7 5 mg
`*AMPHETAMINES**-*AMPH ETAMINES'“'*
`
`ADDl;RALL ORAL TABLE!" I0 MG, 12.5 MG, 15
`MG, 20 MG, 30 MG, 5 MG, 7.5 MG
`
`

`
`Drug Status
`
`Drug Details
`
`__
`
`7
`
`Tier 1
`
`Tier I
`Tn-r 3
`
`Tier 2
`
`Tier 1
`
`NC
`
`Tief3
`
`PA; DS; QL
`
`QL
`PA; N 1; QL
`
`PA; QL
`
`PA; D3; QL, AL
`
`DS. QL
`
`N2
`
`I
`
`L
`
`LA
`
`W
`
`i
`i
`i ED; as-, N1; N3
`
`‘
`
`|
`
`‘Tier.’ 3"
`Li] ;Q7°::;_
`A
`Tigr 3
`LLLLL
`
`
`
`-
`
`Wu
`7
`
`L?L
`
`. LA
`LA
`LA
`1:1‘
`LA
`
`i
`
`-
`
`-W
`
`”
`
`N3
`
`——Tier 3*
`
`LA
`
`N3
`
`_
`
`W
`
`—
`
`XI:.NICAL
`L*AN;I"I-OBESl'I7'Y AGENTS“-*SEROTONIN 2C
`RECEPTOR AG_0NIS'I‘S***
`BWI0
`*ATTENTlON-DEFICITIHYPERACTIVITY
`
`msonmzn (ADHD) AGENTS“-*ADHD
`AGENT - SELECTIVE ALPHA ADRENERGIC
`AGONISTS***
`
`
`
`clnnidine ha er
`uuanfacine hcl er am! (able! €xf€?'1‘v.1t.'C1_;'l.‘1£’£a'.Ix'€
`If mg
`Tier 3
`IINTUNIV
`2015 Aetna Pharmacy Plan I)-rug, Lust-¥Three Tier Open Individual Plan
`(LIpda1cd“3f0|/2015)
`
`24 hr-*
`
`Tier 3
`
`PA; OL
`
`QL
`
`PA, ST, N]; #; QL
`
`4
`
`Page 10
`
`Drug—Name
`
`dexrroamphetamine sulfate oral table:
`
`methamphetamine PIC!
`PROCENTRA
`
`VYVANSE ORAL CAPSULE 10 MG
`
`VYVANSE. ORAL CAPSULE 20 MG, 30 MG, 40
`
`I
`
`I
`
`7
`MG, 50 MG, 60 MG, 70 MG
`ZENZEDI ORAL TABLET 10 MG, 5 MG
`ZLNZEDI ORAL TABLET 15 M0, 2.5 MG, 20 MG,
`30 MG, 7.5 MG
`*ANALEPTICS**;:LNALF‘.PTICS***
`CAFCITHORAL
`..*AN0"1,zEx1ANTS'
`.NON-AMPHETAMINE“'*—*ANOREXLANT
`
`
`
`COMI#i§INA1'IONSf‘_**’__
`
`QSYMIA
`*ANORl«‘.xIAN’l‘S
`N ON-AMPHETAM lNE**—*ANOREXIANTS
`NON-AMI’HETAMINE"'**
`
`ADIPEX-P ORAL TABLE;l"_
`benzphemmine hm’
`DIDREX
`
`diethylpropion he} oral
`phendimetrazfne tartra.:e
`phendimelrazine tartrute er
`phentermine hcl oral
`Rumex
`SUPRENZA
`
`*ANTI-OBESITY AGEN'i_‘S“'-*7LIPASE
`
`INI-II_Bl'I‘0RS***
`ALL-I
`
`_
`
`

`
`Drug Name
`}](fiAI_I;\{:5\Y ORAL TABLET EXTENDED RELEASE
`at
`*ATTENTION—DEFICITfI-IYPERACTIVITY
`
`DISORDER (ADHD) AGENTS*"‘—*ADH_D
`AGENT - SELECTIVE NOREPINEPHRINE
`
`REUPTAKE INHIB_lTOR***
`STRATTERA ORAL CAPSULE 10 MG, 1ddMG',7 13
`MG, 25 MG, 40 MG, 60 MG,80 MG
`T
`¥§.TIMuLAN'1‘s - Misc.**.*sT|M6i.}§17ITs -
`
`Drug Status
`1 my 3
`
`T Drug Details
`PA; N] ; QL
`
`her 2
`
`Q1
`‘
`
`*
`
`T
`
`TT
`
`MISC.***
`CONCERTA ORAL TABLET
`
`T
`
`_
`
`TT
`
`TT
`
`TT
`
`T __TT
`
`EXTENDILDRELE-‘.ASE"‘ 18 MG, 27 MG, 36 MG, 54
`MG
`
`‘.
`
`Tier 3
`
`T
`
`T_
`
`ST; DS; N1; QL; AL
`
`TT
`
`.
`
`
`_ _ Tier3T __ _
`Tier I
`T T_
`
`PA; ST; DS; NI; #; QL; AL
`DS; QL
`
`T ;PA; QL
`
`PA; DS; QL; AL
`
`
`
`'
`
`._ .
`
`_
`
`.
`
`.
`
`‘
`
`PA; sr; DS; N1; QTL
`
`s1"; DS; N1; #; QL; AL
`
`T
`DAYTRANA
`dexmethyfplzfnfdate hc!
`Tdexmethylphenidate ha! er oral capsule extended
`;releu.se 24 hour 10 mg, 5 mg
`dexmerhylphenidare hcl er oral capsule extended
`release 24 hour 15 mg, 30 mg, 46T? mg
`Tie} 3
`_
`.
`FOCALIN
` _ .
`FOCALIN XR
`Tier 3
`
`
`[Her I
`
`Tier I
`
`
`
`METADATF. co ORAL CAPSULE EXTEN om ;
`RELEASE“ 10 MG, 20 MG, 30 MG, 40 MG, 50 MG
`
`
`METADATE CD ORAL CAPSULE EXTENDED
`RELEASE 60 MG
`
`
`
`
`
`I
`
`T
`
`.
`T” 3
`
`‘
`_
`_
`ST’ D3’ N" Q1‘
`
`ST; DS; N1; QL; AL
`Tier 3
`I *_ T 135+ 01»
`. _
`_ '
`Tm’ 3
`Q1“
`Tier .2
`" _ PA;TST; N1; QL
`Tier 1
`DS; QL; AL
`Ilcr l__
`TQL
`_
`{DS; QL; AL
`
`QL
`DS; QL
`PA
`
`‘PA, DS; 0L
`
`PA;DS;QL
`
`PA, DS; QL
`
`PA. DS; N] , QL
`
`PA, ST; DS; NI; QL
`
`W
`
`Page 11
`
`
`
`Tier I
`Tier 1
`Tier 1
`
`-
`
`.-nadafinfl
`
`NUVIGH. ORAL TABLET I50 MG. 200 MG, 250
`MOT 50 MG
`'
`
`PROVIGIL
`
`QLILLIVANT AR
`
`RITALIN
`
`T
`
`_
`
`T
`
`T
`
`Tier 1
`
`.
`'her3
`
`Tier 3
`
`Tier 3
`
`Tier3
`
`2015 Actna Pharmacy Plan Drug List - Three T1er()pen Individual Pian
`(bpdaled 08/O1/20* R)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`_
`— —
`
`METHYLIN ORAL SOLUTION 10 MG/SML, 5
`MG/SML
`METHYLIN ORAL TABLET CHEWABLE
`methylphenidate halter Tea)
`
`me!/2y1phem‘dare hcl er +'fa)T
`methylphenidate hc! er oralTobie! extendedreIea5e"‘
`18 mg. 27 mg. 3T6 mg, 54 mg
`gggifihenfdate hcl oral solution I0 mg/5m}, 5
`methyflaherridufe hcl oral tabir-.r
`merhylpheniddie ho! oral Iabimr chewable
`
`

`
`_
`
`Drug Name
`RITALIN LA ORAL CAPSULE EXTENDED
`RELEASE 74 HOUR 10 MG, 20 MG, 30 MG, 40 MG
`RIIALIN SR
`*'*A;\-TII-1BlCIDES*
`
`‘\
`
`*AMEBlCIDES**—*AMEBICIDES***
`
`YODOXIN
`
`"'AMl.\'0GLYCOSIDES*
`
`*AMINOGLYCOSlDES"*-" AMINOGLYCOSID
`Esifiir
`
`__.._____..T_.._r._.__
`
`Drug Status
`..
`1'“ 3
`Ticr3
`
`I
`
`Brug Details
`_
`I
`I
`ST’ D5’ N" Qt‘ AL
`PA;Si;DS;Nl;QL
`
`'
`
`Tier: '
`
`Db‘
`
`BETHKIS
`neomvcin s-uifare oral
`paromomycin sulfate oral
`TOBI
`TORI PODHALER
`tTibramyc'in inhalation
`"‘ANALG ES [CS - ANTI-INFLA1\r'I.VIATORY*
`
`" W
`
`Tier 3
`
`DS
`
`_
`
`i
`
`
`
`' PA; 31); us; QL
`
`*ANTIRHEUMATIC — ENZYME
`INHIBITORS**- "'ANTIRHEUMATIC - JAN US
`
`KINASE (JAK) [NHIBITORS***
`XELJANZ
`mi
`*AN'I'IRHEUMATIC
`ANTIMETABOLITES“-*ANTIRHEUMATIC
`
`I
`
`|
`
`N
`
`PA; sp; D_s_;__QL
`
`ANTlME'I7'AiBOLITF,S** *
`.**"“‘
`' "'
`
`'OTREXUP
`i
`if
`*AN'I‘I-TNF-ALPHA — MONOCLONAL
`ANTIBODIES“-*ANTI-TNF-Al,PHA —
`
`MONOCLONAL AN'Tl'lBUDIES***_*
`HUMIRA PEDIATRIC CROHNS START - " T
`
`
`
`I-lL;M1RA(SIJBCUTAM‘;r)US* 10 MG/0.2ML
`;*GOLD COMPOUNDIS“-‘GOLD
`‘COMPOUNDS"’**
`RIDAU3 :: L
`*1NTERLEUKlN-l
`BLOCK.ERS**-HNTERLEUKIN-1
`BLOCKERS***
`ARCAISIST
`*INTERLEL'Kl N-IBETA
`BLOCKERS”-*INTERLEUKIN-IBETA
`BLOC KERS* * *
`
`Tier 2
`
`‘PA
`
`Tier 2
`
`PA, 01,
`
`-
`
`I
`
`Tier 3
`
`'
`
`[PA-, so; DS
`
`_
`
`11 ARI.»
`
`|
`
`Tier 3
`
`PA; SD; DS: QL
`
`jj
`
`2015 Aema Pharmacy P'an Drug Lisl — Three Tier Open Individual Plan
`(Updated U810]/2U} S)
`
`6
`
`Page 12
`
`

`
`
`
`’I‘ier3
`
`‘PA;SD;DS_?(—gI;
`
`_
`
`i!" T
`#
`
`7A:'_Fi_e=;r 3
`Tier 3
`
`#; QL.
`5
`
`
` Drug Name
`*INTERLl~‘.UK.IN:6 Ri=3CEProR
`lNHIBl'I‘0RS**- WNTERLEUKIN-6 RI-ZCEPTOR
`INHIBlTORS“'*
`1 W1
`I
`ACTEMRA SIUBCUTANF-.OUS*
`‘WONSTEROIDAL ANTI-IN FLAMMATORY
`
`[
`
`AGENTS (NSAlDS)*"'-*CYCLO0XYGENASE 2
`
`3(C0X-2) INHIBlTORS***
`HCELEBREX
`ceiegoxib oral
`*NONSTEROIDAL ANTIJNFLAMMATORY
`
`7- "
`
`T
`
`AGENTS (NSAIDS)**—* NONSTEROIDAL
`ANTI-INFLAMMATORY AGENT
`('()MBINATIONS*‘“'
`
`
`
`
`
`ARTHROTEC
`
`diclofcnac-mfsaprosrol
`
`
`
`
`
`
`
`
`
`
`
`gwonsn-:Ro1i)AL AN TI-INFLAMMATORY
`AGENTS (NSA[DS]**-*NONSTER(“)IDAL
`ANTI-lNFLAl\_?[MAT__0RY AGENTS (NSAIDS W-
`ANA PROX
`ANAPROX DS
`LCA.TAFI7AM‘
`DAYPR0
`diclofunac potasxium
`dicfufenac sodium er
`drclcfimac ‘sodium oral Iablet delayed release 25 mg,
`50 fng
`Jic~!qfenéc rnriium orai tablet delayed release 75 mg L her 1
`EC-NAPRO?
`etudulac er
`
`I
`
`T
`
`T?
`Tier 3
`_ -15
`""#k";Tcr 3
`__
`“er 3 —
`Her %
`L
`W Tier 1
`7
`I iv!‘ I
`_
`Z _ “er I
`_ 7:
`
`ejjuluc oral
`F ELDENE
`
`fenuprqfm calcium oral capsule
`,'m0proj..-n Lulcium oral tablet
`
`
`
`urfiiprqren urn!
`IB!
`|‘|~’.OFEf\- COMFORT PAC
`if7upr01‘.~'n um! !ubleL.'_:1*0U mg, 600 m 800 me
`|.\HOCl"~1 V fiwji
`muocm ORAL
`
`
`2!)! 5 Aeina Pharmacy Plan Drug List - Three Tier Open Individual Plan
`(Updatcd 03/0112015)
`
`Page 13
`
`

`
`Drug Name
`indomethacin er
`
` indomerhacin om!
`
`T
`__
`
`I
`
`Drug Details
`Drug Siafus
`___..____..._.___,_4...____
`Tier I
`
`lier I
`ketoprofen er
`Tier I
`rceroproxen oral _
`kewroiacrromerhamineorai
`
`H
`
`MELOXICAM COMFORT PAC
`
`'
`
`
`
`meloxicam oraf tablet
`M0316
`
`NALF ON ORAL. CAPSULI-1400 MG
`
`NAPRELAN ORAL TABLET EXTENInan
`
`RELEASE 24 HR* 375 MG, 500 MO. 750 MG
`
`I-NC
`‘Her I iiii 7’
`
`N2
`
`L
`
`_
`
`Drug Note
`Tier I
`T55 5 ii—
`Tie? V
`ll
`Tier 2
`
`1’ Tier 3
`
`_
`
`' —
`
`NAPROXEN COMFORT PAC
`naproxen oigirsuspension
`napkcxéii (Ara: tablet —
`nuproxen sodium oral table: 2 75 mg
`nupr;ciiiei1—.$_(Jdium oral tablet 550 mg
`uoxaprazin
`piroxicumgal capsule I0 mg
`
`iroxicum oral capsule 20 mg
`PONSTEL
`
`SPRIX
`
`sulindac oral
`
`toimetin sodium
`
`VOLTA

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket